ArticleTranslational andrology and urology2025
Financial considerations among adult men undergoing vasectomy: cost analysis and modeling of outpatient costs associated with vasectomy.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A noted barrier to men pursuing vasectomy is the out-of-pocket cost associated with the procedure and required follow-up. Published cost ranges vary widely, may be poor proxies for actual patient cost experience and often fail to include the cost associated with pre-procedure visits and post-vasectomy semen analyses (PVSAs). The study aims to identify a realistic total cost for men undergoing vasectomy. Methods: We examine the charges and payments associated with a vasectomy procedure inclusive of any associated pre-procedure office visit, procedure, and follow-up semen analysis. Data on cost for the pre-procedure office visit and procedure were derived from actual charges/payments for 200 consecutive patients seen in a single medical system between 2022 and 2023. Cost of semen analyses were derived from patient-reported and/or published out-of-pocket costs for LabCorp™, local fertility clinic(s), and Fellow Results: In Model 1 (maximum cost model), the base out-of-pocket cost was $350 plus the cost of PVSA ($139) for an estimated total of $489. The Model 1 average cost was $466. In Model 2 (minimum cost model), the base cost was $276 plus the cost of PVSA ($139) for an estimated total of $415. The Model 2 average cost was $384.42. When incorporating facility fee of $500 with variable insurance coverage, there is a wider range of out-of-pocket cost from $384.42 (full coverage in Model 2) to $1,026 (full facility fee out-of-pocket in Model 1). Conclusions: Based on real-world patient data, there is a definable range of out-of-pocket cost for an insured patient including outpatient visit, vasectomy procedure and PVSA of $384-489. The main driver of variability in cost stemmed from facility fee and the insurer contribution toward this cost. This broadens the definable range of out-of-pocket cost to $384-1,026.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.